New hope for tough cancers: experimental drug shows promise in Late-Stage trial
Disease control
Completed
This study tested a drug called utidelone in 126 people with advanced solid tumors (like stomach, pancreatic, or ovarian cancer) that stopped responding to standard treatments. The goal was to see if the drug could shrink tumors and how safe it was. Researchers measured tumor siz…
Phase: PHASE2 • Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 02, 2026 07:23 UTC